Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/10/058875
CTRI/2023/10/058875
Recruiting
未知

se of vasopressin versus phenylephrine to reduce blood loss during laparoscopic myomectomy- a randomised controlled trial. - NI

All india institute of medical sciences Patna0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: O- Medical and Surgical

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
All india institute of medical sciences Patna
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
All india institute of medical sciences Patna

Eligibility Criteria

Inclusion Criteria

  • •1\.Age between 15\-49 years.
  • •2\.BMI between 18\-29\.9\.
  • •3\.1\-5 symptomatic intramural myomas
  • •4\.Presenting with abnormal uterine bleeding, pelvic pressure or pain, infertility or recurrent miscarriage and are candidates for abdominal myomectomy.
  • •5\.Largest uterine fibroid size of \<10 cm
  • •6\.not pregnant at the time of presentation (i.e. negative urine pregnancy test or last menstrual period within the last 4 weeks);
  • •7\.appropriate medical status for laparoscopic surgery (American Society of Anesthesiologists Physical Status Classification 1 or 2\).

Exclusion Criteria

  • •1\.History of previous abdominal or pelvic surgery except Cesarian section.
  • •2\.History of pelvic or ovarian endometriosis or abdominal tuberculosis.
  • •3\.Patient with subserous or submucosal fibroid or adenomyoma.
  • •4\.Patients who are not candidate for laparoscopic myomectomy.
  • •5\.any pelvic abnormalities requiring concomitant surgery
  • •6\.myoma with a maximal diameter of 10 cm based on pre\-operative ultrasound
  • •7\.Allergy to phenylephrine and vasopressin
  • •8\.Hypertension, Diabetes Mellitus, Cardiac and pulmonary diseases. (ASA \>2\)
  • •9\.Obesity BMI \> 30 kg/m².
  • •10\.Anemia Hb \< 10 g/dL.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Infusion of low dose of vasopressin versus phenylephrine for prevention of cardiopulmonary bypass induced vasoplegic syndrome in patients undergoing coronary artery bypass grafting surgeryCardiopulmonary bypass induced vasoplegic shock.Diseases of arteries, arterioles and capillariesI70-I79
IRCT201408201127N2Vice Chancellor for Research of Tabriz University of Medical Sciences75
Completed
Not Applicable
Assessment of Vasopressin effect on reduction of bleedingVasopressin.Other and unspecified hormone antagonists
IRCT201108173773N4Tehran University of Medical Sciences and Health Services80
Completed
Not Applicable
Effects of Vasopressor on the Graft Blood Flow in TRAMBlood FlowAnastomotic Failure of FlapFlap NecrosisFlap Ischemia
NCT05049278Seoul National University Hospital20
Recruiting
Not Applicable
Cardiac function and cerebral blood flow in the beachchair surgical patient.Intraoperative cerebral hypoperfusionHaemodynamic state in the Beachchair position during shoulder surgeryAnaesthesiology - AnaestheticsSurgery - Surgical techniquesStroke - Ischaemic
ACTRN12610001075077The Avenue Hospital34
Completed
Not Applicable
Study on medication used in children with stop working of heartHealth Condition 1: I95-I99- Other and unspecified disorders of the circulatory system
CTRI/2019/01/017200The Director90